We studied Heinz body-containing erythrocytes with three different unstable hemoglobins: Nottingham, Brockton, and unclassified. We demonstrated two classes of membrane protein defects in unstable hemoglobin-containing cells (UHRBCs), a defect of the spectrin-depleted inside-out vesicle (UH-IOV), and a defect of spectrin (UH-spectrin) itself.
Introduction
The inner surface of the erythrocyte membrane incubates in a concentrated hemoglobin solution (300 mg/ml) throughout the 120-d life of the cell. At these concentrations, hemoglobin interacts with membrane proteins, binds to the cytoplasmic domain ofprotein 3 (1) (2) (3) (4) (5) (6) (7) (8) , and stabilizes the self-association of spectrin, the major structural protein of the membrane skeleton (9) . The modification of the erythrocyte membrane by abnormal hemoglobins is emerging as an important theme in the attempt to understand the pathophysiology of membrane damage in hemoglobinopathies and the process of erythrocyte senescence (10) (11) (12) (13) (14) (15) (16) (17) .
We have studied the function of structural proteins of erythrocytes from patients with homozygous sickle cell anemia (SS-RBC)1 and have demonstrated decreased binding of normal spectrin to its high-affinity binding site (ankyrin) on inside-out vesicles from patients with homozygous sickle cell anemia (SS-IOVs) (10) . Although this binding defect is not reversible by reduction with dithiothreitol (DTT), we suspect that it is an oxidative lesion caused by oxygen radicals which have been demonstrated by Hebbel and colleagues to be generated in excess in SS-RBCs (18) . In fact, Rank and co-workers (19) have shown (using thiol-disulfide exchange chromatography) that SS-RBCs do contain increased amounts of oxidized membrane proteins, including ankyrin (19).
In an attempt to dissect the pathogenesis of the membrane damage in SS-RBCs, we examined membrane protein function in other pathological erythrocytes which are exposed to oxidation, but not sickling. We looked specifically at Heinz body-containing unstable hemoglobin-containing erythrocytes (UH-RBCs) and erythrocytes treated with acetylphenyl hydrazine (APH-RBCs).
Unstable hemoglobin Koln erythrocyte membranes have been well documented by Flynn and colleagues to exhibit evidence of lipid and protein oxidation (20) , and have increased protein thiol oxidation analagous to SS-RBCs as measured by Rank et al. (19) . Superoxide anion is readily produced by the autoxidation of hemoglobin Koln, a reaction which is favored in this intrinsically "unstable" hemoglobin because of its abnormal tertiary structure, a result of an amino acid substitution near the stabilizing heme pocket (p98; Val --Met). Such autoxidant-prone unstable tertiary structure is present in our patient with another heme pocket abnormality, hemoglobin Nottingham (p98; Val --Gly), and in our patient with hemoglobin Brockton, in which the alpha helix is disrupted by the presence of an aberrent proline (,' 38; Ala -Pro). The biochemical lesion in our patient with the unclassified hemoglobin is not known.
Acetylphenylhydrazine, phenylhydrazine, and hydrazine generate Heinz bodies and activated oxygen radicals within erythrocytes (21) , and cause oxidation of membrane lipids and proteins (22, 23) . Waugh and Low (12) and Low and colleagues (13) have focused on phenylhydrazine-induced hemoglobin oxidation to hemichrome, and its binding to and modulation ofthe organization of protein 3 (12, 13) , a feature that is also found in SS-RBCs (16 Preparation ofmembranes and membrane proteins. Venous blood was collected in citrate-phosphate-dextrose and stored at 40C for up to 5 d. Abnormal blood samples were stored for up to 48 h. Erythrocyte membranes were prepared by hypotonic hemolysis (24) . Isotonic membrane shells were prepared from membranes in a modification of the method of preparing shells from whole cells by incubating them in a buffer of the following composition: Triton X-100 150 mg/ml, NaCl 150 mM, Hepes 24 mM, EGTA 1 mM, phenylmethylsulfonyl fluoride (PMSF) 10 ,ug/ml, leupeptin (Sigma Chemical Co., St. Louis, MO) 10 ;Lg/ml, pepstatin A (Sigma Chemical Co.) 10 ,ag/ml, pH 7.0, 5 min, 0C (25) . IOVs were separated from low ionic strength extracts by centrifugation, and purified by dextran sedimentation (26) . Rightside-out vesicles (ROVs) were produced by resealing erythrocyte membranes as described (27) .
Spectrin dimer was extracted from erythrocyte membranes at 370C in 0.1 mM sodium phosphate, pH 8, purified by gel-filtration chromatography (24) , and stored at 0C in either IOV-binding buffer (KCI (28) to be uncontaminated by tetramer. Spectrin was also extracted from erythrocyte membranes at 0OC according to the method of Liu and colleagues (9) , and subjected to PAGE under nondenaturing conditions to estimate the degree of spectrin self-association in the native membrane.
Protein 4.1 was extracted from erythrocyte membranes depleted of glyceraldehyde-3-phosphate dehydrogenase (protein 6), spectrin, and actin, using 1% Tween 20 (Fisher Scientific Co., Springfield, NJ) as described by Liljas and colleagues (29) and modified by Becker and colleagues (30) . The extract was chromatographed on a column of DEAE-cellulose (DE-52, Whatman Chemical Separation Inc., Clifton, NJ) equilibrated in a buffer of the following composition: glycine (0.05 M), EGTA (0.5 mM), and DTT (0.5 mM), pH 9.8. Purified protein 4.1 was eluted with a continuous gradient of 0-0.5 M NaCl in the same buffer. Tubes from the upslope of the protein 4.1 peak were uncontaminated with glycophorin. The purified protein was stored at 0°C, and used within 7 d.
The 72-kD spectrin-binding fragment of ankyrin was released from
IOVs by cleavage with a-chymotrypsin and purified by DEAE-cellulose chromatography as described by Bennett (31) . Rabbit muscle Gactin was prepared and polymerized to F-actin as described by Spudich and Watt (32) . Spectrin was radioiodinated with Bolton-Hunter reagent (New England Nuclear, Boston, MA) (33) .
Preparation ofHeinz Bodies in control erythrocytes. Control erythrocytes were incubated at an hematocrit of 5%, at 370C, for 2 h in a buffer of the following composition: NaCl (140 mM), KCG (5 mM), MgCI2 (1 mM), glycylglycine (20 mM), dextrose (10 mM), bovine serum albumin (1 mg/ml), penicillin (100,ug/ml), streptomycin (100 ,ug/ml), gentamycin (15 ,Ag/ml), pH 7.4, with or without 15 mM acetylphenylhydrazine. The cells were then washed either three or six times in 37.5 vol of buffer without APH to remove the APH, and then resuspended to an hematocrit of 5% and incubated at 37°C, for up to 48 h in the same buffer.
Assessment of membrane sidedness. The proportion of IOVs or ROVs that was inside-out was assessed by measuring glyceraldehyde-3-phosphate dehydrogenase activity (in duplicate) spectrophotometrically before and after the addition of 0.2% Triton X-100 (27) .
Assays of membrane protein interactions. Rebinding of 25I.-spectrin to spectrin-depleted IOVs was measured as described by Goodman and Weidner (26) . Samples of '25I-spectrin were heat denatured (70'C, 10 min) and tested at every I25I-spectrin concentration in each experiment. Such measurements showed that 5-10% ofthe total spectrin was nonspecifically bound. Specific binding was calculated as total binding minus nonspecific binding. All spectrin binding experiments are presented with each point representing the mean of duplicates.
The binding of UH-spectrin (patient 1) and control spectrin to F-actin was assessed in the presence and absence ofcontrol protein 4.1 as described by Becker and colleagues (30 Binding of control 72-kD ankyrin fragment, UH-72 kD, and APH-72 kD to control spectrin was determined in a non-denaturing gel system. The 1251 72-kD fragment was incubated with control spectrin for 60 min at 0°C in conditions described above for the spectrin-IOV interaction. The samples were then electrophoresed for 18-24 h at 40C without detergent in a slab gel similar to what was described by Morrow and Marchesi (34) except with an acrylamide gradient of 2-6%.
Other techniques. Protein concentration of membranes and IOVs was estimated according to the method of Lowry et al. (35) . Concentrations of purified spectrin, actin, and protein 4.1 were determined spectrophotometrically. Sodium dodecyl sulfate (SDS)-PAGE was performed by the methods of Steck (36), Fairbanks et al. (37) , and Laemmli (38) . Nondenaturing PAGE of purified spectrin was done using a modification of the Steck method (36), omitting SDS, and using 3% acrylamide. The amounts of spectrin, ankyrin, protein 3, actin, or globin in erythrocyte membranes IOVs, or shells, were quantitated by cutting out bands 1, 2, 2.1, 3, or 5 from Coomassie Brilliant Blue-stained SDS-PAGE slabs, eluting the dye overnight in 1 ml pyridine (25%), and reading the optical density of the eluate at 605 nm (39) . Blot transfer of gel proteins to nitrocellulose was performed in a water-cooled system in 25 mM Tris, 192 mM glycine, 20% (vol/vol) methanol, at 350 mA for 3 h. The transferred proteins were stained with amido black and/or were blocked and immunostained (Protoblot, Promega, Madison, WI) after having been exposed to rabbit antibodies to spectrin, ankyrin, or protein 4.1.
Results
Composition ofmembranes, vesicles, shells, andprotein preparations. Comparison of SDS-PAGE of control and UH-RBC membranes reveals increased globin and catalase (as seen in many other hemolytic anemias) (40) and decreased spectrin (previously seen only in the various forms of hereditary spherocytosis and pyropoikilocytosis variants) (41) (42) (43) (44) in the UH-RBC membranes. Quantitation ofspectrin by pyridine elution revealed that control erythrocytes (two individuals with three and five determinations, respectively) had a spectrin/protein 3 ratio of0.92±0.08. UH-RBC membranes (patients 1, 2, and 3, each with five determinations) had a spectrin/protein 3 ratio of 0.61±0.14. The ratio of spectrin to globin in whole cell preparations was 0.32±0.04 in control and 0.22±0.02 in patient 2. Neither whole cells, nor isotonic shells of either control or UH-RBCs revealed spectrin degradation products by nitrocellulose transfer and immuno staining with rabbit antispectrin antibody (Fig. 1) .
Ankyrin quantitation showed no difference between control (ankyrin/protein 3 ratio 0.186±0.055) and UH-IOVs (0.168±0.053), but a decrease in the amount of ankyrin in UH-shells. Control shells had an ankyrin/actin ratio of 1.86±0.51 with a ratio of 0.19±0.07 in the UH-shells (patient 2). Immunostaining of protein transfers from control and UH-shells revealed no significant proteolysis of the UH-ankyrin when probed with antiankyrin antibody (Fig. 1) .
In ,0000-apparent in the unstable hemoglobin preparation (Fig. 2) . In nondenaturing PAGE of control spectrin and UH-spectrin extracted at 370C, the same predominance of dimer is seen in both preparations, but the faster-running band is seen in the UH-spectrin extracts, but not in the controls. This band was not abolished by treatment with 100 mM DTT at pH 8, 00C overnight, and did resolve only into bands 1 and 2 when run in the second dimension with SDS (Fig. 3) . As seen in Fig. 5 , the spectrin binding capacity of APHIOVs prepared from erythrocytes that were exposed to 15 mM APH for 2 h (conditions which produced numerous large Heinz bodies) and then washed free of APH, was normal. In contrast, APH-IOVs from erythrocytes incubated with APH under the same conditions, washed free of APH (either three or six times in 37.5 vol of buffer without APH), but then allowed to incubate without APH for 48 h, had markedly diminished spectrin binding. During the incubation, more hemoglobin became associated with both the control and APHIOVs. After the initial 2-h incubation without APH, control IOVs had a hemoglobin/protein 3 ratio of 0.03±0.01. This ratio increased to 0.1±0.01 after the 48-h incubation. After the initial incubation with APH, APH-IOVs had a high hemoglobin/protein 3 ratio of 0.17±0.02. After further incubation of these cells for 48 h without APH, considerably more hemoglobin became associated with the APH-IOVs, with a hemoglobin/protein 3 ratio of 1.2±0.08.
The binding of control 72-kD, UH-72-kD, and APH-72-kD ankyrin fragments to spectrin is shown in Fig. 6 . The left side of the figure represents denisitometry tracings from the autoradiograph of the same slab. The top panel shows the mobility of '25I-control 72-kD fragment alone and is indicated by the arrow. In the panel below it, unlabeled spectrin was added, and the position of the spectrin-72-kD complex is indicated by the arrow. Despite the altered mobility of the UH-72-kD and APH-72-kD fragments in this non-denaturing system, both preparations ran in identical position in denaturing gels. As seen in Fig. 7 , the fast-moving material seen in the nondenaturing dimension is of the same apparent molecular weight, and reacts with antiankyrin antibody as does the control material.
The ankyrin binding site of UH-spectrin is normal. The ankyrin-binding site of UH-spectrin is examined by comparison ofthe binding of 1251-UH-spectrin and control 1251I-spectrin to control IOVs. No difference in binding is observed (Fig. 8) , indicating that the ankyrin binding site of UH-spectrin (patient 1) is normal.
The binding of UH-spectrin to F-actin in the presence of protein 4.1 is reduced. The enhancement ofbinding ofspectrin to actin by protein 4.1 was studied by comparing UH-spectrin (patient 1) and control spectrin binding to F-actin in the presence and absence of protein 4.1. As seen in Fig. 9, both (46) , and men (41, 42, 44) . Decreased binding ofspectrin to UH-IO Vs. The diminished capacity of UH-IOVs to bind to normal spectrin is even more profound than what we observed with SS-IOVs (Fig. 4) , or what has been observed in one family with hereditary elliptocytosis (47). As we have previously shown (10) , this decreased In an attempt to examine the role of oxidation in the creation of the UH-IOV spectrin binding lesion, we exposed normal erythrocytes to APH. The various hydrazines interact with oxyhemoglobin in intact erythrocytes, and in a matter of minutes generate superoxide, H202, and Heinz bodies (21, 22) . We were surprised to find that after incubating in APH for 2 h, although virtually every erythrocyte was laden with Heinz bodies, APH-IOVs bound spectrin normally (Fig. 5) the membrane and disassociate at low ionic strength at 370C, ability to bind to F-actin, and ability to exhibit enhanced binding to F-actin in the presence of protein 4.1. We found that UH-spectrin bound normally to normal IOVs (Fig. 8) , and bound normally to F-actin in the absence of protein 4.1 (Fig.  9) . However, in the presence of protein 4.1, UH-spectrin binding to F-actin was not enhanced to the same degree as control (Fig. 9) . The relative degree of spectrin self-association in the membrane was normal, as was the tendency for the spectrin to dissociate into dimers at 370C in low ionic strength (Fig. 1) . However, a faint band of spectrin, running slightly faster than spectrin dimer, was seen on nondenaturing PAGE in the UHspectrin preparations (both at 00C and at 370C) but not in the controls (Fig. 1) . This band was most pronounced in conditions favoring dimer formation, and appeared in the purified dimer peak eluted off a gel-filtration column. A band of this mobility and composition was described as "fast mobility band" by Becker and her colleagues (45) , and was produced by treating normal spectrin with the oxidizing agent, diamide (diamide-spectrin).
In fact, the resemblance between UH-spectrin and diamide-spectrin is not only in the appearance of the fast mobility band, but in the entire pattern of spectrin function. Both UH-and diamide-spectrins bind normally to IOVs, convert readily to dimer or tetramer under appropriate conditions, bind normally to F-actin in the absence of protein 4.1, and fail to exhibit enhanced binding to F-actin in the presence of protein 4.1. However, there are subtle differences between these two species of spectrin: the fast mobility band of UH-and diamide-spectrins are similarly dysfunctional, but the UHspectrin lesions are less readily reversible than the diamideinduced spectrin lesions.
Decreased spectrin content in UH-RBC membranes. We quantitated the amount of spectrin in UH-RBC membranes and found it to be markedly reduced. Reduction in spectrin content had been previously documented only in hereditary spherocytosis and pyropoikilocytosis erythrocytes (41) (42) (43) (44) . Although the osmotic fragility profiles ofUH-RBCs do not reveal a population of osmotically fragile cells, there are between 5 and 10% spherocytes identifiable on peripheral smears. The mechanism of the spectrin deficiency is unknown even in hereditary spherocytosis. Here it is possible that UH-RBCs acquire an oxidative lesion of spectrin that allows them to behave functionally like the rare (spectrin-deficient) hereditary spherocytosis patients with genetically impaired spectrin which has lost the ability to bind normally to F-actin in the presence of protein 4.1 (48, 49) .
In summary, we find two classes of membrane protein lesions in UH-RBCs, a lesion(s) ofthe UH-IOV, and a lesion(s) of UH-spectrin itself. The UH-IOV lesion is a functional defect of the spectrin binding site of ankyrin which is more profound than what we demonstrated in SS-IOVs. The UH-spectrin lesion involves spectrin deficiency as well as a pattern of normal and abnormal functions which resembles the pattern of diamide-spectrin. This suggests that damage to UH-RBC membranes may be a gradual process that results from globin deposition and oxidation in vivo.
